CTDX FIRST Trademark

Trademark Overview

On Tuesday, November 9, 2021, a trademark application was filed for CTDX FIRST with the United States Patent and Trademark Office. The USPTO has given the CTDX FIRST trademark a serial number of 97116712. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Friday, August 16, 2024. This trademark is owned by Agilent Technologies, Inc.. The CTDX FIRST trademark is filed in the Pharmaceutical Products and Medical Instrument Products categories with the following description:

Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for cancer detection, monitoring and therapy selection; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer detection, monitoring and therapy selection

Blood collection kit comprised of blood collecting tubes and vials
ctdx first

General Information

Serial Number97116712
Word MarkCTDX FIRST
Filing DateTuesday, November 9, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateFriday, August 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 26, 2022

Trademark Statements

Goods and ServicesMedical diagnostic reagents and assays for testing of body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for cancer detection, monitoring and therapy selection; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in cancer detection, monitoring and therapy selection
Goods and ServicesBlood collection kit comprised of blood collecting tubes and vials

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE
International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, November 17, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameRESOLUTION BIOSCIENCE, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressKIRKLAND, WA 98033
Party NameAgilent Technologies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95051
Party NameAgilent Technologies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSanta Clara, CA 95051

Trademark Events

Event DateEvent Description
Friday, November 12, 2021NEW APPLICATION ENTERED
Wednesday, November 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 23, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, February 23, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, February 23, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, February 23, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 23, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, May 18, 2022ASSIGNED TO EXAMINER
Wednesday, May 25, 2022EXAMINERS AMENDMENT -WRITTEN
Wednesday, May 25, 2022EXAMINERS AMENDMENT E-MAILED
Wednesday, May 25, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, May 25, 2022EXAMINER'S AMENDMENT ENTERED
Wednesday, June 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, July 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 15, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 20, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, March 15, 2023SOU EXTENSION 1 FILED
Wednesday, March 15, 2023SOU EXTENSION 1 GRANTED
Friday, March 17, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, September 12, 2023SOU EXTENSION 2 FILED
Tuesday, September 12, 2023SOU EXTENSION 2 GRANTED
Thursday, September 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 7, 2024AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, February 19, 2024SOU EXTENSION 3 FILED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, February 16, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 19, 2024SOU TEAS EXTENSION RECEIVED
Monday, February 19, 2024SOU EXTENSION 3 GRANTED
Tuesday, February 20, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 16, 2024SOU TEAS EXTENSION RECEIVED
Friday, August 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 16, 2024SOU EXTENSION 4 FILED
Friday, August 16, 2024SOU EXTENSION 4 GRANTED

Related Keywords

first ctdx diagnostic comprised medical reagents assays monitoring blood detection selection therapy